Servier accomplished its acquisition of Day One Biopharmaceuticals and its buyout of Edgewise Therapeutics’ neuromuscular enterprise is predicted to shut later this 12 months. On the BIO Worldwide Conference, Servier’s prime enterprise growth government defined the rationale for these offers and the way they match the corporate’s general technique.
The submit Servier Govt: ‘We Are Not In search of Blockbusters, We’re In search of Progressive Science’ appeared first on MedCity Information.
